Dual-market notes · 4 min read

One Brand, Two Buyers

Two buyers rarely want the same proof, even when they're buying the exact same product.

A hospital buyer and a factory safety officer do not read the same words the same way, even when they're looking at the exact same exoskeleton. One wants clinical outcomes and provider ROI. The other wants injury prevention and a defensible safety record. Same technology, two entirely different reasons to say yes.

Companies serving two markets tend toward one of two mistakes. They build separate brands for each, which fragments the company and dilutes the case for why either market should trust it. Or they build one brand that hedges its language until it's vague enough to technically apply to both, and compelling to neither.

What holds them together

A shared spineThe requirement
One underlying reason the company exists, that both markets are downstream of. Not a shared tagline. A shared reason.
Distinct entry pointsThe requirement
Each market gets its own language, proof, and value proposition, built for how that specific buyer evaluates a purchase, rather than a softened version of the other market's pitch.
Proof that stays in its laneThe requirement
Clinical evidence for a hospital buyer and safety data for an industrial buyer aren't interchangeable. Using one to reassure the other market usually reads as irrelevant rather than additive.
One system, two applicationsThe requirement
Visual identity and voice stay consistent so the company reads as one credible entity, even as the specific claims flex by audience.

The Ekso Bionics work on this site is a direct example. EksoHealth, clinical rehabilitation, and EksoWorks, industrial safety, share one brand spine but run distinct narratives: one built around patient outcomes and provider ROI, the other around injury prevention and workforce safety. Neither pretends to be the other. Both trace back to the same underlying capability.

A dual-market brand doesn't average two audiences into one. It holds one truth and translates it twice.

A useful test: pull the language built for each market and swap it. If the industrial pitch would confuse a hospital buyer, and the clinical pitch would fall flat with a plant manager, the split is doing its job. If either version could plausibly work for both audiences, the positioning probably isn't specific enough for either.

The discipline isn't choosing one market over the other. It's resisting the pull toward language soft enough to fit both, which tends to end up compelling neither.

Ashley Pola · Brand & narrative strategy · Get in touch
FAQ
What is narrative architecture?+
In a dual-market company, it's the shared logic underneath two distinct buyer narratives, the reason both markets are downstream of the same underlying capability, even when the language never overlaps.
What's the difference between branding and brand strategy?+
Branding is the identity two markets both see. Brand strategy is the decision that determines how far the language can diverge by audience before the company stops reading as one credible entity.
What does a brand and narrative strategist do?+
I build brand architecture like the Ekso Bionics work on this site: one spine, distinct narratives per buyer, each held to its own proof and language.
Should a dual-market company use one brand name or two?+
Usually one, with sub-brands or product lines carrying the market-specific distinction. Splitting into two unrelated brand names tends to cost more in shared credibility than it gains in message precision.
How do you keep two buyer narratives from confusing each other?+
Keep the proof separate. Clinical evidence and industrial safety data shouldn't cross into each other's materials. The two narratives can share a visual system and still never share a case study.